Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

4.73USD
8:59pm GMT
Change (% chg)

$-0.05 (-1.05%)
Prev Close
$4.78
Open
$4.85
Day's High
$4.92
Day's Low
$4.69
Volume
100,959
Avg. Vol
236,174
52-wk High
$13.24
52-wk Low
$1.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.72 -0.464
Jun '17 1.76 -0.598
Mar '17 1.37 -0.730
FY 2016 Dec '16 1.46 -0.757
Sep '16 0.91 -0.920
Jun '16 1.90 -0.976
Mar '16 0.87 -1.020
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 5.10 5.60 4.60 3.80
Quarter Ending Jun-18 2 5.20 5.60 4.80 4.10
Year Ending Dec-18 2 21.80 22.59 21.00 16.08
Earnings (per share)
Quarter Ending Mar-18 2 -0.35 -0.19 -0.52 --
Quarter Ending Jun-18 2 -0.33 -0.14 -0.52 --
Year Ending Dec-18 2 -1.28 -0.60 -1.96 -2.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 148.59 32.90
P/E High - Last 5 Yrs. -- 73.40 45.97
P/E Low - Last 5 Yrs. -- 21.18 24.37
Beta -- 0.92 0.89
Price to Sales (TTM) 3.91 10.37 5.77
Price to Book (MRQ) -- 4.10 5.41
Price to Tangible Book (MRQ) -- 5.03 6.98
Price to Cash Flow (TTM) -- 19.14 23.42
% Owned Institutions 12.18 25.26 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.76 1.50
Dividend Yield - 5 Year Avg -- 0.72 1.52
Dividend 5 Year Growth Rate -- 8.18 5.21
Payout Ratio(TTM) -- 25.13 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.12 8.74 9.24
Sales (TTM) vs TTM 1 Yr. Ago 10.34 3.59 5.59
Sales - 5 Yr. Growth Rate -- 4.24 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 38.76 50.85 19.65
EPS (TTM) vs TTM 1 Yr. Ago 16.12 -- --
EPS - 5 Yr. Growth Rate -- 5.27 10.73
Capital Spending - 5 Yr. Growth Rate -- 11.73 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.45 1.74 2.18
Current Ratio (MRQ) 1.58 2.25 2.97
LT Debt to Equity (MRQ) -- 40.36 12.22
Total Debt to Equity (MRQ) -- 49.15 16.52
Interest Coverage (TTM) -14.93 23.22 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 11.12 54.98 54.70
Gross Margin - 5 Yr. Avg. -- 54.59 52.42
EBITD Margin (TTM) -379.92 -- --
EBITD - 5 Yr. Avg -- 16.98 10.86
Operating Margin (TTM) -404.13 -4.62 4.64
Operating Margin - 5 Yr. Avg. -- 8.64 6.26
Pre-Tax Margin (TTM) -432.67 -4.32 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 7.75 6.60
Net Profit Margin (TTM) -432.78 -6.49 1.76
Net Profit Margin - 5 Yr. Avg. -- 5.54 2.91
Effective Tax Rate (TTM) -- 17.40 23.04
Effective Tax Rate - 5 Yr. Avg. -- 19.80 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 14,074,948 855,668,157
Net Income/Employee (TTM) -- 1,183,084 100,655,595
Receivable Turnover (TTM) 3.18 5.26 5.78
Inventory Turnover (TTM) 2.77 4.95 3.35
Asset Turnover (TTM) 0.21 0.77 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -92.89 -1.08 10.98
Return on Assets - 5 Yr. Avg. -- 4.95 12.37
Return on Investment (TTM) -158.24 9.38 14.43
Return on Investment - 5 Yr. Avg. -- 6.70 16.18
Return on Equity (TTM) -1,928.83 14.72 16.13
Return on Equity - 5 Yr. Avg. -- 9.60 17.47
  1 Year 3 Year 5 Year
Sales % 27.00 31.78 --
EPS (TTM) % 27.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for HTG Molecular Diagnostics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.43%
# of Holders: 25
Total Shares Held: 3,740,401
3 Mo. Net Change: 1,701,083
# New Positions: 6
# Closed Positions: 7
# Increased Positions: 11
# Reduced Positions: 10
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.